Facebook
X
LinkedIn
Forward
0755_SHVGR_HIPEC: Turning Up the Heat in Ovarian Cancer_Live
Description
HIPEC (Hyperthermic Intraperitoneal Chemotherapy) is emerging as a powerful tool in the treatment of epithelial ovarian cancer, offering new possibilities for patients who previously faced limited options. This lecture, led by Dr. Katie K. Crean-Tate, examines how HIPEC is changing the landscape of care—beginning with an overview of current treatment pathways and their impact on patient prognosis and experience. The session will provide a clear understanding of the science behind HIPEC, including its mechanism of action during surgery and the rationale for its use in advanced cases. Drawing on real-world clinical evidence, the lecture will also address patient selection criteria, helping clinicians identify those most likely to benefit from this intensive yet potentially life-altering therapy. Looking ahead, the course will explore promising innovations such as minimally invasive techniques that may broaden access to HIPEC and further improve outcomes for women with ovarian cancer.
Assembly Bills 1195 & 241- Culturally Appropriate Care which is Free of Implicit Biases:
Social Determinants of Health (SDOH) / Cultural or Linguistic Considerations
Gęca, K., Litwiński, J., Ostrowski, T., Świetlicka, I., Polkowski, W. P., & Skórzewska, M. (2024).
Exploring the Survival Determinants in Recurrent Ovarian Cancer: The Role of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Journal: Cancers, Volume: 16, Issue: 11, Article: 2150
Rybin A., Maksymovskyi V., Kuznetsova O., Zamyshlyak V. (2025).
Personalised treatment of patients with advanced ovarian cancer: comparative analysis of surgical approaches.
Journal: Journal of Education, Health and Sport, Volume: 83, Page: 64576, Published: June 30, 2025.
DOI: 10.12775/JEHS.2025.83.6457
Rijken A., Lurvink R.J., Luyer M.D.P., et al. (2021).
The burden of peritoneal metastases from gastric cancer: a systematic review on the incidence, risk factors and survival.
Journal: Journal of Clinical Medicine, Volume: 10, Issue: 21, Article: 4882
DOI: 10.3390/jcm10214882
Target Audience
Nurse Practitioner (NP)
Nurse, Registered (RN)
Pharmacists (PharmD)
Physicians (MD or DO)
Physician Assistant (PA)
Physical Therapists
Psychologists
Social Workers
Other Healthcare Professionals
Students of Health Professions
Learning Objectives
By the end of this learning activity, participants will be able to:
1.) Review typical treatment paradigm and prognosis for patients with epithelial ovarian cancer.
2.) Describe technique and therapeutic rationale behind using hyperthermic intraperitoneal chemotherapy (HIPEC).
3.) Identify appropriate patient populations for HIPEC and summarize key clinical evidence.
4.) Discuss emerging directions for HIPEC, including minimally invasive approaches and expanded eligibility criteria.
Disclosure of Financial or In-Kind Commercial Support & Conflict of Interest
Gnanagurudasan Prakasam, MD, a planning team member for this activity, receives consultant fees from Novo Nordisk (related to growth hormones), Medtronic (related to insulin pumps), Dexcom (related to glucose sensors), Mankind (related to inhaled insulin), Alexion (related to HPP), and K Kirin (related to XLH) as well as speaker fees from Lilly (related to diabetes), Sanozi (related to Diabetes Type 1 prevention), and Abbvie (related to puberty). These ineligible relationships were deemed not relevant to this activity’s topic, and thus mitigation was not needed.
Sophia Humphreys, PharmD, a planning team member for this activity has recently ended financial relationships with the following ineligible companies: Pharmacosmos (ended 12/2023), Fresenius Kabi (ended 10/2022), and Heron (ended 10/2022).
No one else involved in the planning or presentation of this educational activity have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. No financial or in-kind commercial support was received to produce or promote this educational activity.
Additional faculty involved the planning of this learning activity are as follows:
Carolin Delker, NP
Max Ingersoll, FNP-BC, MSN
Jill Kacher Cobb, MD
Tam Nguyen, MD
Lori Petrini
Michelle Mah
Luanne Ridgley, LSW
Christopher Mack
– Provider Designee/Verification: Fozia Ferozali, Ed.D
Accreditation
In support of improving patient care, Sutter Health, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.
Credit Designation Statement
Sutter Health designates this LIVE activity for a maximum of 1.00 AMA PRA Category 1 Credits™ for physicians, 1.00 Non-Physician Participation Credit for physician assistants, 1.00 continuing professional development contact hours for nurses, 1.00 ACPE credit hours for pharmacists, 1.00 general continuing education credits for social workers, 1.00 PTBC continuing education credits for physical therapists, and 1.00 IPCE Credit Hours for other healthcare clinical disciplines.
Note to Other Disciplines: Non-Physician Participation Credit (AKA - AMA PRA Category 1 Credits HOURS™) Continuing Medical Education is acceptable for meeting the continuing education requirements for Pharmacists, Physician Assistants, Psychologists, Registered Nurses, and Respiratory Care Practitioners. For other disciplines, please check with the regulatory board for your discipline to confirm what type of credits meet the continuing education requirements. Continuing education hours for nurses accredited by ANCC, via Joint Accreditation.
Attendance & Credit Claiming
Text the 6-letter attendance verification code to (916) 866-7913 to claim credit.
Available Credit
- 1.00 ACPE
Pharmacy Credit - Accreditation Council of Pharmacy Education (ACPE)
Sutter Health designates this Live activity for a maximum of 1.00 of ACPE credit(s). Credits for pharmacists and technicians will be transmitted to CPE Monitor and will be available within 60 days post-activity pending submission of individual NABP e-PID and DOB (mm/dd only). Pharmacists should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 AMA PRA Category 1 Credit™
Physician Credit
Sutter Health designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™ for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 Non-Physician Participation Credit
Sutter Health designates this Live activity for a maximum of 1.00 Non-Physician Participation Credit. Non-Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AMA PRA Category 1 Credits HOURS™ Continuing Medical Education is acceptable for meeting the continuing education requirements for Pharmacists, Physician Assistants, Psychologists, Registered Nurses, and Respiratory Care Practitioners. For other disciplines, please check with the regulatory board for your discipline to confirm what type of credits meet the continuing education requirements. Continuing education hours for nurses accredited by ANCC, via Joint Accreditation.
- 1.00 ANCC
Nursing Credit - American Nurses Credentialing Center (ANCC)
Sutter Health designates this Live activity for a maximum of 1.00 ANCC contact hour(s). Nurses should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 ASWB-ACE
Social Work Credit
As a Jointly Accredited Organization, Sutter Health is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 1.00 continuing education credits.
- 1.00 CA BRN
Nursing Credit - California Board of Registered Nursing (CA BRN)
This activity is approved for 1.00 contact hour(s) by Sutter Health, which is an approved provider by the California Board of Registered Nursing. (Provider Number 17182). Nurses should claim only the credit commensurate with the extent of their participation in the activity. - 1.00 IPCE
This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.
- 1.00 PTBC
Physical Therapy Board of California
Sutter Health designates this Live activity for a maximum of 1.00 PTBC credit(s). Physical therapists should claim only the credit commensurate with the extent of their participation in the activity.